CO-DIAGNOSTICS, INC. (CODX)

1.21 -3.97% (-0.05)

Over 5Y: -99.6%

2026-08-28
100 200 300
2021 2022 2023 2024 2025 2026

Financials Quarterly

Q3 '25 — Revenue: 145.4K Q3 '25 — Operating Cash Flow: -5.9M Q3 '25 — Free Cash Flow: -6M Q3 '25 — Net Income: -5.9M Q4 '25 — Revenue: 263.9K Q4 '25 — Operating Cash Flow: -6.2M Q4 '25 — Free Cash Flow: -6.3M Q4 '25 — Net Income: -25.7M Q1 '26 — Revenue: 146K Q1 '26 — Operating Cash Flow: -7.8M Q1 '26 — Free Cash Flow: -8M Q1 '26 — Net Income: -9.1M Q2 '26 — Revenue: 166.1K Q2 '26 — Operating Cash Flow: -7.2M Q2 '26 — Free Cash Flow: -7.2M Q2 '26 — Net Income: -6.3M -24M -18M -12M -6M 0 6M
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.7
SBC / sales 169.9%
ROIC -567.6%
Accruals -120.3%
Gross margin 43.5%
Asset turnover 0.043×
ROA -283.6%
ROCE -356.7%
ROE -370.2%
EBITDA margin —
FCF margin —
OCF / EBIT —
OCF margin —
OE margin —
Oper. margin —
Profit margin —

2 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.3
RPO / sales 0.04×
RPO growth —
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

4.9
ND/EBITDA —
Cash runway 0.21 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 1.5×
F-score 1.1 pts
Cash / Debt —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Sales CAGR 4Y -71.8%
Sales/sh Y/Y -45.4%
Sales Q/Q +2.0%
Shares change +31.6%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.